NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $63.4M
This Quarter Return
-10.87%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
10 Year Return
AUM
$322M
AUM Growth
Cap. Flow
+$322M
Cap. Flow %
100%
Top 10 Hldgs %
93.06%
Holding
24
New
24
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 68.19%
2 Financials 28.98%
3 Communication Services 0.18%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EAR
1
DELISTED
Eargo, Inc. Common Stock
EAR
$115M 35.8% +2,886,724 New +$115M
NFH
2
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$93.3M 28.98% +8,350,000 New +$93.3M
KRTX
3
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$26.8M 8.32% +234,811 New +$26.8M
HRMY icon
4
Harmony Biosciences
HRMY
$2.12B
$21.7M 6.74% +768,708 New +$21.7M
BOLT icon
5
Bolt Biotherapeutics
BOLT
$9.85M
$18M 5.61% +1,166,952 New +$18M
BEAM icon
6
Beam Therapeutics
BEAM
$1.66B
$6.26M 1.95% +48,660 New +$6.26M
GRTX
7
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$6.03M 1.87% +613,223 New +$6.03M
NVTA
8
DELISTED
Invitae Corporation
NVTA
$4.88M 1.52% +144,667 New +$4.88M
XENE icon
9
Xenon Pharmaceuticals
XENE
$2.98B
$3.69M 1.15% +197,880 New +$3.69M
NFH.WS
10
DELISTED
New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
$3.67M 1.14% +1,580,000 New +$3.67M
VIR icon
11
Vir Biotechnology
VIR
$686M
$3.25M 1.01% +68,663 New +$3.25M
SRRA
12
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.55M 0.79% +130,979 New +$2.55M
ARDX icon
13
Ardelyx
ARDX
$1.53B
$2.47M 0.77% +325,233 New +$2.47M
EXAS icon
14
Exact Sciences
EXAS
$8.98B
$2.17M 0.67% +17,464 New +$2.17M
ALXO icon
15
ALX Oncology
ALXO
$62.7M
$1.91M 0.59% +34,950 New +$1.91M
OTIC
16
DELISTED
Otonomy, Inc.
OTIC
$1.9M 0.59% +851,000 New +$1.9M
KALV icon
17
KalVista Pharmaceuticals
KALV
$678M
$1.89M 0.59% +78,720 New +$1.89M
DBVT
18
DBV Technologies
DBVT
$264M
$1.56M 0.48% +285,500 New +$1.56M
RUBY
19
DELISTED
Rubius Therapeutics, Inc
RUBY
$1.39M 0.43% +56,768 New +$1.39M
EXEL icon
20
Exelixis
EXEL
$10.1B
$1.17M 0.36% +64,200 New +$1.17M
RETA
21
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.17M 0.36% +8,265 New +$1.17M
FLNT
22
Fluent
FLNT
$57.8M
$571K 0.18% +194,799 New +$571K
SYBX icon
23
Synlogic
SYBX
$17M
$267K 0.08% +68,634 New +$267K
AKRO icon
24
Akero Therapeutics
AKRO
$3.74B
$86K 0.03% +3,470 New +$86K